ScholarIQanswers from OpenAlex & ORCID
Laurence H. Baker
ResearcherPublications, citations & collaboration network
Laurence H. Baker is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Laurence H. Baker have?
ScholarIQindexed works
Laurence H. Baker has 390 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Laurence H. Baker have?
ScholarIQcitation count
Laurence H. Baker has 23,451 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Laurence H. Baker?
ScholarIQh-index
Laurence H. Baker has an h-index of 71 in OpenAlex.
What is the i10-index of Laurence H. Baker?
ScholarIQi10-index
Laurence H. Baker has an i10-index of 185 in OpenAlex.
What is the ORCID of Laurence H. Baker?
ScholarIQorcid
The ORCID for Laurence H. Baker is on the source record.
What is the OpenAlex record for Laurence H. Baker?
ScholarIQopenalex
The OpenAlex for Laurence H. Baker is on the source record.
What are the most-cited papers on Laurence H. Baker?
ScholarIQmost cited works
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
Integrative clinical genomics of metastatic cancer
Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro, Pankaj Vats, Erin F. Cobain, Jessica N. Everett, Xuhong Cao, Erica Rabban, Chandan Kumar‐Sinha, Victoria M. Raymond, Scott M. Schuetze, Ajjai Alva, Javed Siddiqui, Rashmi Chugh, Francis P. Worden, Mark M. Zalupski, Jeffrey W. Innis, Rajen Mody, Scott A. Tomlins, David R. Lucas, Laurence H. Baker, Nithya Ramnath, Ann F. Schott, Daniel F. Hayes, Joseph Vijai, Kenneth Offit, Elena M. Stoffel, J. Scott Roberts, David C. Smith, Lakshmi P. Kunju, Moshe Talpaz, Marcin Cieślik, Arul M. Chinnaiyan
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael Fanucchi, David C. Harmon, Scott M. Schuetze, Denise K. Reinke, Peter F. Thall, Robert S. Benjamin, Laurence H. Baker, Martee L. Hensley
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
George D. Demetri, Sant P. Chawla, Margaret von Mehren, Paul S. Ritch, Laurence H. Baker, Jean‐Yves Blay, Kenneth R. Hande, Mary Lou Keohan, Brian L. Samuels, Scott M. Schuetze, Claudia Lebedinsky, Yusri Elsayed, Miguel Izquierdo, Javier Gómez‐Román, Youn C. Park, Axel Le Cesne